OTHER ASSETS

3 Months Ended

Mar. 31, 2024

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

OTHER ASSETS

8. OTHER ASSETS

The following table summarizes the Company’s other current assets for each of the periods indicated:

	As of March 31, 2024		As of December 31, 2023
	(in thousands)
Collaboration and other receivables	$	30,092	$	29,786
Prepaid maintenance services		15,907		11,281
Prepaid clinical and pre-clinical expenses		11,552		10,280
Tax-related receivables and prepaids		7,274		6,862
Prepaid commercial expenses		3,231		2,729
Interest receivable		3,209		2,731
Prepaid insurance		1,952		3,352
Prepaid research expenses		1,672		2,512
Other		8,076		8,181
Total other current assets	$	82,965	$	77,714

The following table summarizes the Company’s other non-current assets for each of the periods indicated:

	As of March 31, 2024		As of December 31, 2023
	(in thousands)
Manufacturing-related deposits and prepaids	$	82,610	$	74,204
Non-current investments		33,919		—
Intangible assets, net		28,930		29,620
Restricted cash*		15,579		15,579
Strategic investments		7,457		6,527
Prepaid maintenance services		4,569		5,466
Other		3,343		5,375
Total other non-current assets	$	176,407	$	136,771

* The Company had approximately $15.6 million in restricted cash included in other non-current assets on the Company’s unaudited condensed consolidated balance sheets as of both March 31, 2024 and December 31, 2023. Restricted cash for both periods relates to (i) letters of credit established under the Company’s various property leases that serve as security for potential future default of lease payments, (ii) a letter of credit established under a certain commercial supply agreement and (iii) collateralized cash for the Company’s credit cards. The restricted cash is unavailable for withdrawal or use for general obligations.